DEEPNOID Inc.
Financials
Valuation Metrics
DEEPNOID Inc.'s Market Cap is ₩472B. At end of 2025 it was ₩953B. Ranked #1775 of 2,436 in KR market (top 73%), #1076 of 1,649 on KOSDAQ (top 65%), #72 of 96 in Health Care Equipment & Services (top 75%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 47.17B KRW | KR#1,775/2,436 Sec#72/96 |
| Revenue | 6.87B KRW | KR#2,325/2,436 Sec#86/96 |
| Net Income | -11.12B KRW | KR—/2,436 Sec—/96 |
| Total Assets | 36.84B KRW | KR#2,290/2,436 Sec#83/96 |
| Net Assets | 24.61B KRW | KR#2,217/2,436 Sec#82/96 |
| Employees | 170 | KR#1,211/2,436 Sec#38/96 |
| Value | ||
| P/B | 1.92x | KR#1,924/2,436 Sec#67/96 |
| P/S | 6.87x | KR#2,209/2,436 Sec#76/96 |
| FCF Yield | -15.34% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | -45.20% | KR#2,253/2,436 Sec#84/96 |
| ROA | -30.18% | KR#2,303/2,436 Sec#87/96 |
| Op. Margin | -159.72% | KR#2,333/2,436 Sec#87/96 |
| Revenue Growth | -62.85% | KR#2,315/2,436 Sec#93/96 |
| Financial Health | ||
| Debt Ratio | 149.73% | KR#1,179/2,436 Sec#62/96 |
| Total Debt | 6.66B KRW | KR#1,731/2,436 Sec#59/96 |
| FCF | -7.24B KRW | KR#1,611/2,436 Sec#57/96 |
| Cash | 5.74B KRW | KR#1,934/2,436 Sec#69/96 |
| Current Ratio | 8.06x | KR#141/2,436 Sec#13/96 |
| Performance | ||
| 1Y Return | -68.61% | KR#2,328/2,436 Sec#93/96 |
| 1M Return | 3.01% | KR#596/2,436 Sec#31/96 |
| From 52W High | -70.73% | KR#2,160/2,436 Sec#79/96 |
| 1Y MDD | -78.38% | KR#2,256/2,436 Sec#90/96 |
| Trading | ||
| Volume | 1,856,906 shares | KR#65/2,436 Sec#2/96 |
| Foreign Own. | 4.29% | KR#855/2,436 Sec#32/96 |
| Per Share | ||
| EPS | -427 KRW | KR—/2,436 Sec—/96 |
| BPS | 838 KRW | KR#2,321/2,436 Sec#90/96 |
Company Info
DEEPNID, an artificial intelligence company established in 2008, listed on KOSDAQ in 2021 under special provisions for technology growth companies. The company operates businesses providing AI solutions for medical diagnosis and interpretation assistance, early disease diagnosis, X-Ray image automatic interpretation, and deep learning-based vision inspection. Leveraging its medical imaging AI technology, DEEPNID is accelerating market entry through the development of generative AI medical solutions and collaboration with the global leader in machine vision market share. DEEPNID is headquartered in Guro-gu, Seoul.